The most potent antiviral tested was plitidepsin (Figure 2D), which targets the eukaryotic Elongation Factor 1A2 (eEF1A2) and has been previously used for the treatment of multiple myeloma. The gene discussed is EEF1A2; the disease is AL amyloidosis.